Health Products Chain Management Analysis.docVIP

 PAGE \* MERGEFORMAT 11 Health Products Chain Management Analysis Since the end of last century chain operations into China from abroad, in the commercial circulation was an unprecedented flourish. In Guangdong, in recent years, a growing number of health care products brand to develop its own chain of stores, has faced fierce competition in the market, some happy some people unhappy, chain cake is great, not so delicious. I respect a client’s actual case, analysis of health care products chain of ideas, to share with readers. Project Background: ** Pharmaceutical Group is a joint venture of state-owned holding company, is the country’s 500 large state-owned enterprise groups, 120 pilot enterprises large groups. Has two subsidiaries listed on the Shanghai Stock Exchange and 29 wholly-owned, holding and shareholding companies. Total registered capital of more than 30 billion yuan, with total assets of 70 billion yuan profit in 2005 nearly 700 million yuan. For many years in the domestic medicine, health care industries, ** Pharmaceutical Group, China’s health care products to see a huge market. As early as in previous years and the reform of national drug distribution channels, ** Pharmaceutical Group, the first step, to develop the commercial distribution channels outside the hospital. As a result, to the group the development of health care products industry, provides a smooth channel for security. It can be said, ** Pharmaceutical Group’s health care products market line, is different from the traditional medicine enterprise, take the prescription drug channel for the hospital, pharmacies and other sources of non-prescription medicines sales model; also different from the traditional health care products companies to go commercial super gift counter channels, direct sales channels and consumer point-of sales model. But from traditional medicine derived channels new hybrid channel model that combines direct marketing, pharmacy, Direct / franchise and chain